Skip to content
PIL Logo

Gammanorm

Last Updated on eMC 22-Jun-2017 View document  | Octapharma Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22-Jun-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Updated on 23-Mar-2015 and displayed until 22-Jun-2017

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 12-Jun-2014 and displayed until 23-Mar-2015

Reasons for adding or updating:

  • Change to section 6 - date of revision

Updated on 21-Mar-2012 and displayed until 12-Jun-2014

Reasons for adding or updating:

  • Change to packaging

Updated on 09-Aug-2010 and displayed until 21-Mar-2012

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Octapharma Limited

Company image
Address

The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB

Fax

+44 (0)161 837 3799

Medical Information e-mail
Telephone

+44 (0)161 837 3770

Medical Information Direct Line

0845 1300 522

Medical Information Fax

+44 (0)161 837 3799

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

human normal immunoglobulin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue